RE:RE:well, looks like I'm all in with ACBThanks for the welcome haha, although ive been in ACB since .99/share. I deffinitely agree with you that there is massive upside potential. CGC's cart is wayyyyy ahead of its horse right now and im waiting for it to catch up with itself before re-entering. CGC and ACB are my two favourite MJ plays based on leadership, profitability and branding. CGC is my top pick because I can deffitely see the potential for it to be bought out at a premium. I bought a few thousand shares last week at 2.38 and more today at 2.12. I sold my OGI and CGC and APH, used that money to buy more of ACB and also made small plays on MJNA, FIN, TBP and VP.
I like MJNA based on it being the first in its market with a nice spread of the market. I feel they are in as good of a place as any company in the american/californian market to benefit when the inevitable descheduling of cannabis happens in america. hopefully i dont have to wait more than a couple years for that.
I like FIN becuse theyve been an established brand in California for a decade, which is an incredible foundation to launch from given the recreational advances made and that are ahead of us all. Its extremely undervalued given its established infrastructure and sales when compared to Tinley, EAT etc. Once the former exploration company changes its name and ticker over, officially settles the deal and makes headway to grab californians by the balls I can see this stock hitting $10 within the next 5 years.
TBP was picked because they seem to be a pure biopharma play in this medical industry and they partnered with mcgill, which hits close to home as im a student here. They partnered with APH, and are an intergrated corporation with a license pending while they develop their pharma side. I see strong potential for patentable ad marketable applications.
VP is currently a piece of sh!t and i dont know why its in my portfolio